Demystifying Highly Potent API And Cytotoxic Drug Products
Source: Pharmaceutics International
By Sharada Kolindrekar, Director of Continuous Improvement, Technology, and Validation (CITV), and Devan Patel, Senior Director, Project Management, Pharmaceutics International, Inc. (Pii)

access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader